How Stellate Ganglion Block (SGB) May Support Nerve Healing and Pain Relief – Insights from New Research
At AIMS, we regularly offer Stellate Ganglion Blocks (SGBs) as part of our integrative approach to managing complex pain and trauma-related conditions. While many patients have already experienced meaningful relief through this safe and minimally invasive technique, emerging research continues to deepen our understanding of how SGB may support the nervous system — not only by relieving pain, but by promoting healing at the cellular level.
Researchers used a spinal cord injury model in rats, a condition that often results in long-lasting neuropathic pain due to nerve damage. In the study, some rats received an SGB after their injury, while others did not.
The outcomes were striking. Rats that received an SGB experienced:
Improved Motor Recovery: They showed faster and more complete improvement in their ability to move.
Reduced Inflammation: Inflammatory markers such as IL-1β, IL-6, and TNF-α were significantly lower in spinal tissue following SGB treatment.
Decreased Pain Sensitivity: SGB-treated rats had higher pain thresholds, indicating a reduction in neuropathic pain.
Lower Rates of Cell Death: Apoptosis, or programmed nerve cell death, was reduced in the SGB group.
Restored Cellular Recycling (Autophagy): SGB enhanced autophagy, the process by which cells clear out damage — a crucial factor in nervous system repair.
Why Is This Relevant for Human Health?
Although this was an animal study, many of the same biological pathways apply to humans. The findings are especially relevant for conditions involving inflammation and nervous system overactivity, such as:
Post-injury or post-surgical neuropathic pain
Persistent sympathetic nervous system activation (commonly seen in trauma and PTSD)
Chronic pain syndromes such as CRPS
This study suggests that SGB may not only interrupt pain signals, but also help regulate the underlying inflammation and cellular dysfunction that often perpetuate chronic pain.
What We See at AIMS
At AIMS, we have already seen positive results using SGB to support patients with:
Post-traumatic stress and anxiety-related symptoms
Long COVID-related nervous system dysfunction
Complex regional pain syndrome (CRPS)
Postoperative or persistent nerve pain
This research adds valuable support to what we witness in clinical practice: SGB appears to offer more than symptom relief — it may help reset and rebalance the nervous system for long-term benefit.
Is SGB Right for You?
If you or someone you care about is struggling with neuropathic pain, chronic inflammation, or trauma-related nervous system symptoms, Stellate Ganglion Block may be a promising option. It’s a quick outpatient procedure with a strong safety profile and growing evidence of benefit.
Contact us at AIMS to schedule a consultation and explore whether SGB could support your recovery.
At AIMS, we regularly offer Stellate Ganglion Blocks (SGBs) as part of our integrative approach to managing complex pain and trauma-related conditions. While many patients have already experienced meaningful relief through this safe and minimally invasive technique, emerging research continues to deepen our understanding of how SGB may support the nervous system — not only by relieving pain, but by promoting healing at the cellular level. A recent study titled “Effects of Stellate Ganglion Block on Inflammation and Autophagy of Spinal Cord Neurons in Rats with Neuropathic Pain After Spinal Cord Injury” (American Journal of Translational Research, 2025) provides compelling evidence that SGB may ...
In the world of modern medicine, few voices resonate as profoundly as Dr. Sunil Aggarwal. As a palliative care physician and ketamine expert, Dr. Aggarwal has been at the forefront of groundbreaking therapies that challenge traditional approaches to healing. His recent conversation with Marc Marcel on the Marc Marcel Podcast offers a rare glimpse into the science, soul, and stigma surrounding psychedelic medicine. Key Topics Covered in the Episode: Psychedelic Healing: How ketamine and other psychedelic therapies are transforming the way we approach mental health and trauma recovery. End-of-Life Care: The role of ketamine in providing comfort and relief for ...
Washington state is on the cusp of a significant transformation in mental health and wellness, driven by a growing movement to decriminalize and medically integrate psychedelic substances like psilocybin. While efforts to fully legalize psychedelic mushrooms statewide have faced hurdles, the dedicated work of medical professionals, activists, and researchers is paving the way for a more progressive approach to mental health care. Leading the Way: AIMS Institute and Dr. Sunil Aggarwal At the forefront of this movement is Dr. Sunil Aggarwal, a renowned palliative care physician and co-director of the Advanced Integrative Medical Science (AIMS) Institute in Seattle. Dr. Aggarwal ...